San Francisco, 06 February, Diabetic Foot Ulcer (DFU) Treatment Market
Analysis Report By Treatment (Biologics, Wound Care Dressings, Therapy
Devices), By Ulcer Type (Ischemic, Neuro-Ischemic, Neuropathic), And Segment
Forecasts, 2019 – 2025.
The global diabetic foot ulcer treatment market size
is expected to reach a value of USD 6.82 billion by 2025, according to a new
report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the
forecast period. Rising prevalence of diabetes, increasing healthcare expenses,
and rapidly growing geriatric population worldwide are some of the major
factors driving the diabetic foot ulcer treatment market.
Diabetic foot ulcers are one of
the most common foot injuries that is caused due to diabetes mellitus.
Management of diabetic foot ulcers aims at fast healing and wound closure, by
adopting a multidisciplinary therapeutic approach so as to avoid amputation.
Among different types of treatment options available, biologics held the
largest share in the diabetic foot ulcer treatment market in 2017. This can be
attributed to strong revenue generated by growth factors that are prescribed
worldwide for their ability to promote generation of new cells and achieve
wound closure. Therapy devices and wound care dressings also offer significant
commercial opportunity due to their cost-effectiveness, ease of availability,
and wide use in combination with other treatments at every level of wound care
management.
Among different ulcer types, neuro-ischemic ulcers led
the market in 2017 with more than 50.0% market share due to higher patient
population suffering from the ulcer type globally. North America represented
the largest share in the global market in 2017 owing to rising prevalence of
diabetes, growing geriatric cohort, increased investment in R&D of novel
therapies, and developed healthcare facilities.
Access Full Research
Report On Diabetic Foot Ulcer (DFU) Treatment Market Analysis:
Further Key Findings From the Study Suggest:
·
The biologics segment commanded
the largest share in 2017 and is projected to retain its position through the
forecast period, due to increased adoption and potential approvals of growth
factors
·
North America dominated the DFU
treatment market in 2017 due to well-established favorable healthcare
reimbursements and infrastructure
·
Asia Pacific is expected to
witness the fastest growth owing to expanding diabetes patient population
driven by increasing healthcare expenses and growing geriatric cohort
·
The neuro-ischemic ulcers
segment accounted for the leading share in 2017. It is likely to experience the
fastest growth during the forecast period
·
The foam and alginate
dressings, skin grafts, and negative pressure wound therapy segments are
anticipated to exhibit significant CAGR over the forecast period
·
Some of the key players in this
space are ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S;
Smith & Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.;
Medtronic Plc.; Organogenesis, Inc.; Molnlycke Health Care AB; and BSN Medical
GMBH.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
global diabetic foot ulcer (DFU) treatment market on the basis of treatment,
ulcer type, and region:
Diabetic Foot Ulcer (DFU)
Treatment Outlook (Revenue, USD Million, 2016 - 2025)
·
Wound Care Dressings
o
Alginate Dressings
o
Hydrofiber Dressings
o
Foam Dressings
o
Film Dressing
o
Hydrocolloid Dressings
o
Surgical Dressings
o
Hydrogel Dressings
·
Biologics
o
Growth Factors
o
Skin Grafts
·
Therapy Devices
o
Negative Pressure Wound Therapy
o
Ultrasound Therapy
·
Antibiotic Medications
·
Others
Diabetic Foot Ulcer (DFU)
Treatment Ulcer Type Outlook (Revenue, USD Million, 2016 - 2025)
·
Neuropathic Ulcers
·
Ischemic Ulcers
·
Neuro-ischemic Ulcers
Diabetic Foot Ulcer (DFU)
Treatment Region Outlook (Revenue, USD Million, 2016 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Full
Press Release of this Report: www.grandviewresearch.com/press-release/global-diabetic-foot-ulcer-dfu-treatment-market
About Grand
View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
For more information: www.grandviewresearch.com/
No comments:
Post a Comment